@iorbellinzona
8 Research groups 120+ Staff members 760+ Issued publications 60+ Awarded PhD degrees www.ior.usi.ch Based in Bellinzona (Switzerland), IOR is affiliated to @usi.ch and member of Bios+ (www.biosplus.ch).
Not registered yet? Take advantage of a 20% discount when registering for #IPCS26 #APCCC26
📍 28 April-2 May 2026, Palazzo Congressi, Lugano, Switzerland
🎟️ Register here: onlineevent.ch/APCCC/2026
🎓 Credits requests: SGU – SSU, SSMO, SRO, SGMN, ECTS and Animal welfare training (FBA)
#IORmoments
As part of the IOR PhD Program, we had the pleasure of hosting Prof. Daniel Peeper, a leading expert in the development of innovative combinatorial therapies.
His talk, “Translating the cancer-immune dialogue”, sparked an inspiring discussion with our PhD community. Thank you!
#IORnews
Tomorrow, the Annual Meeting of the International Extranodal Lymphoma Study Group (IELSG) begins in Bellinzona, bringing together global experts in the study and treatment of extranodal lymphomas.
Read more: ior.usi.ch/events-news/...
Check out the complete programme of the #IPCS26!
apccc.org/ipcs/
Register now for #IPCS26 and #APCCC26 and take advantage of a 20% discount when registering for both events!
Events Details:
📍 28-29 April 2026, Palazzo Congressi, Lugano, Switzerland
🎟️ Register here: onlineevent.ch/APCCC/2026
⏳ Early registration for the International Prostate Cancer Symposium (IPCS26 @ipcsymposium.bsky.social ) is closing soon — final deadline: February 28.
👉 Secure your spot before February 28: apccc.org/apccc-2026/r...
ICML has a fresh new branding and website — check it out!
#IORmoments
Last week, we were delighted to welcome Prof. Margot Thome to the IOR Lecture Series for her lecture: “Insights into antigen receptor signaling: how the protease MALT1 controls lymphocyte activation and lymphomagenesis.”
We thank Prof. Thome for a stimulating presentation!
#IORmoments
On Friday, we hosted Prof. Vincenzo Bronte (University of Verona) as part of the IOR PhD Program for his lecture “Evolution of the immune contexture and myeloid cell dynamics in pancreatic cancer immune evasion.”
Thank you, Prof. Bronte, for your insightful and inspiring discussion.
The Bellinzona Institutes of Science (Bios+), IOR and IRB, wish you happy Holidays and a happy 2026!
#IORmoments
On December 19, 2025, HC Ambrì-Piotta played a solidarity match at the Gottardo Arena in support of La Corsa della Speranza.
The team wore a special event jersey, later auctioned to support cancer research in Ticino.
👕 Some jerseys are still available until December 29:
hcap.ch/it/asta
#IORnews
Major awards to IOR and IOSI at SOHC 2025 in Basel.
Congratulations to Prof. Franco Cavalli, Prof. Davide Rossi, Prof. Anastasios Stathis, and Dr. Ghilardi for their well-deserved recognitions.
Read more: ior.usi.ch/events-news/...
#IORnews
🎉 Congratulations to Dr. Lisa Pavinato, Postdoctoral Fellow in the Stem Cells and Cancer Lab led by Prof. Arianna Baggiolini on receiving the prestigious Brain & Behavior Research Foundation Young Investigator Grant!
🔗https://shorturl.at/BnMjx
⏳ One month left to submit your abstracts for the International Prostate Cancer Symposium 2026!
Don’t miss the December 12, 2025 deadline to submit your work for IPCS 2026.
This is a great opportunity to showcase your research to leading experts shaping the future of prostate cancer care ⬇️
#IORnews
On the occasion of the 75th anniversary of Switzerland’s recognition of the People’s Republic of China, IOR and IOSI will represent Swiss scientific excellence at a high-level event in Beijing dedicated to oncology research collaboration.
Read more: ior.usi.ch/events-news/...
IOR&IOSI for #Movember
Many of our researchers dedicate their work to understanding & treating #prostatecancer. This effort is strengthened by our long-standing partnership with IOSI, which has led to exciting discoveries from the lab to the clinic.
Don’t forget to get checked - prevention matters.
#IORnews
🎉 Congratulations to Dr. Jonas Van Lent on receiving the prestigious AFM-Téléthon Trampoline Grant!
This highly competitive grant supports promising early-career scientists developing bold and innovative projects in rare diseases.
🔗 shorturl.at/ghhNJ
#IORnews
🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer.
Learn more: ior.usi.ch/events-news/...
#IORmoments
Today we were delighted to host Prof. Dr. Zoran Culig from the Medical University of Innsbruck for his lecture on “Androgen receptor coactivators in advanced prostate cancer” in our PhD Lecture Series.
Thank you for such an inspiring talk!
#IORnews
Congratulations to Prof. Davide Rossi, Group Leader at IOR and Deputy Head of Hematology at IOSI, on his appointment as Full Professor at USI within the Faculty of Biomedical Sciences.
🔗 ior.usi.ch/events-news/...
#IORnews
IOR and IRB researchers (Theurillat & Cavalli labs) identify first-in-class inhibitors of FOXA1/FOXA2, long deemed “undruggable” drivers of prostate cancer.
➡️ Learn more: ior.usi.ch/events-news/...
#IORnews
An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma.
Learn more: ior.usi.ch/events-news/...
#PinkOctober
🎀 October is Breast Cancer Awareness Month
At IOR, we stand at the forefront of the fight against breast cancer. Our Cancer Immunotherapy Lab studies how cancer cells interact with bacteria and the immune system to develop new therapies.
Let’s raise awareness - prevention saves lives.
We had the honor to host Dr. Taewan Kim (DIGIT, South Korea) for a special seminar at IOR. He is renowned for pioneering Parkinson’s disease modeling using human pluripotent stem cells. Thank you for the inspiring talk!
#IORjobs
Open positions in the Stem Cells and Cancer Lab, directed by Arianna Baggiolini:
- PhD Student: ior.usi.ch/events-news/...
- Lab Technician: ior.usi.ch/events-news/...
Apply now and join Baggiolini’s international and inspiring team!
#IORmoments
Many thanks to Prof. Markus Gerhard for today’s lecture in our PhD Lectures Serie!
We truly appreciated his time and the stimulating discussion with our community.
#IORnews
IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies.
🔗Learn more: ior.usi.ch/events-news/...
🌐 The IOR Foundation has a brand-new website!
Discover more about our Foundation, which manages:
- our Institute, the IOR
- The International Extranodal Lymphoma Study Group (IELSG)
- The International Conference on Malignant Lymphoma (ICML)
🔗 www.foundationior.ch
#IORnews
The Lab of Prof. J.P. Theurillat together with Dr. M. Bolis created the Prostate Cancer Atlas, a web-based platform that empowers the research community to explore, compare, and analyze data with unprecedented ease and flexibility.
🔗 short-url.org/1ecu9
www.youtube.com/watch?v=qTjJ...
#IORnews
A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL.
Learn more: tinyurl.com/ytybcbr8
#IORnews
The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies.
🔗Read more: ior.usi.ch/events-news/...
@calcinottolab.bsky.social
